{"result": "(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Nutritional support provided through enteral means, involving the administration of nutrients directly into the gastrointestinal tract.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL CENTRAL<|>EVENT<|>Nutritional support provided through central venous access, allowing for the delivery of nutrients directly into the bloodstream.)\n##\n(\"entity\"<|>CVC<|>ORGANIZATION<|>Central Venous Catheter (CVC) is a device used to access the central venous system for the administration of nutrition and medications.)\n##\n(\"entity\"<|>HICKMAN®<|>ORGANIZATION<|>Hickman® is a type of tunneled central venous catheter used for long-term access to the bloodstream.)\n##\n(\"entity\"<|>BROVIAC®<|>ORGANIZATION<|>Broviac® is a type of central venous catheter designed for pediatric patients requiring long-term intravenous access.)\n##\n(\"entity\"<|>GROSHONG®<|>ORGANIZATION<|>Groshong® is a type of central venous catheter that features a unique valve to prevent blood from entering the catheter when not in use.)\n##\n(\"entity\"<|>PORTH-A-CATH®<|>ORGANIZATION<|>Porth-a-cath® is a type of implanted port used for long-term intravenous access, typically for chemotherapy or nutrition.)\n##\n(\"entity\"<|>ANESTESIA Y REANIMACIÓN<|>ORGANIZATION<|>Anesthesia and Resuscitation services responsible for the placement and management of central venous catheters.)\n##\n(\"entity\"<|>CIRUGÍA<|>ORGANIZATION<|>Surgical services involved in the placement of central venous catheters through surgical dissection.)\n##\n(\"entity\"<|>RADIOLOGÍA PEDIÁTRICA INTERVENCIONISTA<|>ORGANIZATION<|>Pediatric Interventional Radiology services that assist in the placement of central venous catheters.)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>NUTRICIÓN PARENTERAL CENTRAL<|>Both are methods of providing nutritional support to patients, but through different routes (enteral vs. parenteral)<|>7)\n##\n(\"relationship\"<|>CVC<|>NUTRICIÓN PARENTERAL CENTRAL<|>CVC is used as a means to administer nutrition in parenteral nutrition therapy<|>8)\n##\n(\"relationship\"<|>HICKMAN®<|>CVC<|>Hickman® is a specific type of CVC used for long-term access<|>6)\n##\n(\"relationship\"<|>BROVIAC®<|>CVC<|>Broviac® is another type of CVC specifically designed for pediatric patients<|>6)\n##\n(\"relationship\"<|>GROSHONG®<|>CVC<|>Groshong® is a type of CVC that features a valve mechanism for ease of use<|>6)\n##\n(\"relationship\"<|>PORTH-A-CATH®<|>CVC<|>Porth-a-cath® is an implanted port that serves as a long-term CVC for patients<|>6)\n##\n(\"relationship\"<|>ANESTESIA Y REANIMACIÓN<|>CVC<|>Anesthesia and Resuscitation services are responsible for the management of CVCs<|>7)\n##\n(\"relationship\"<|>CIRUGÍA<|>CVC<|>Surgical services may perform the surgical placement of CVCs<|>7)\n##\n(\"relationship\"<|>RADIOLOGÍA PEDIÁTRICA INTERVENCIONISTA<|>CVC<|>Pediatric Interventional Radiology assists in the placement of CVCs<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: puede utilizar como complemento de la nutrición enteral.\n\nSe canalizarán preferentemente las venas de mayor calibre. El lugar de venopunción\nse preparará por desinfección preferiblemente con clorhexidina acuosa al 2% dejan-\ndo secar. Una vez colocado el catéter, cubrir con un apósito estéril transparente.\n\nLas complicaciones más frecuentes son edema, inflamación y flebitis. Como medida\npreventiva se recomienda la rotación de venas cada 3-4 días.\n\n### 1.2.NUTRICIÓN PARENTERAL CENTRAL.\n\nLa NP por vía central es una solución que accede a la circulación por una vena de\ngran calibre.\n\nSe emplea un catéter venoso central (CVC) y se canaliza (percutáneamente o por\ndisección quirúrgica) habitualmente la vena yugular interna, subclavia, yugular ex-\nterna, femoral, safena o ilíaca y la punta del catéter se sitúa en la vena cava superior,\ncava inferior o próxima a la entrada de la aurícula.\n\nExisten varios tipos de catéter para el acceso venoso central: epicutáneo-cava o ca-\ntéteres centrales de inserción periférica (PICC) y catéteres centrales para tratamien-\ntos domiciliarios o de larga duración. Estos últimos que se recomiendan cuando la\nduración de la NP se prevea que va a ser superior a 3-4 semanas, pueden ser tuneli-\nzados (tipo Hickman®, Broviac®, Groshong®) o implantados (reservorios subcutá-\nneos: Porth-a-cath®).\n\nLa colocación del catéter seguirá una técnica estéril. Su instauración o recolocación,\nen caso necesario, estará asegurada las 24 horas del día por parte del personal fa-\n\n223\n---\ncultativo de los servicios de Anestesia y Reanimación o Cirugía y/o Radiología Pediá-\ntrica Intervencionista.\n\nEl diámetro del CVC debe ser el más pequeño posible para minimizar el riesgo de\nlesión de la vena. En la tabla siguiente se recogen las recomendaciones del tamaño\ndel catéter según la edad.\n\n| Edad | PICC* | Tunelizados | Reservorios |\n|------|-------|-------------|-------------|\n| < 1 año | 2,0-5,0 Fr<br>1-2-3 luces | 2,7-4,2 Fr<br>1 luz | Usados raramente |\n| 1-3 años | 4,0-5,5 Fr<br>1-2-3 luces | 3,0-5,0 Fr<br>1 luz | Preferible usar catéteres |\n| 4-11 años | 5,0 – 7,0 Fr<br>2-3 luces | 4,2 – 7,0 Fr<br>1 – 2 luces | 0,6 – 1,0 mm de diámetro<br>interior |\n| Adolescentes | 5,0 – 8,5 Fr<br>2-3 luces | 5,0 – 12,5 Fr<br>1-2-3 luces | 0,8 – 1,4 mm. De diámetro<br>interior |\n\nTabla.- Tamaño recomendado de los catéteres según la edad. *PICC:catéter central\nde inserción periférica. (Gomis et al, 2007).\n\nPermiten emplear NP con osmolaridad de hasta 1600 mOsm/L y si la punta del ca-\ntéter venoso está en el atrium auricular,se pueden alcanzar osmolaridades de 2.000\nmOsm/l sin riesgo para el paciente. Las soluciones con lípidos ayudan a disminuir la\nosmolaridad de la NP.\n\nLos apósitos transparentes estériles tienen como función proteger el catéter de las\ninfecciones ,traumatismos y roturas. El protocolo de manejo del catéter y el trata-\nmiento de las complicaciones se especifica en el Anexo .\n\n## 2.-NECESIDADES NUTRITIVAS\n### 2.1.Fluidos\n\nLas recomendaciones de fluidos para la NP según la edad son:\n\n| Edad (años) | Fluidos (ml/Kg/día)<br>(Volumen máximo entre paréntesis) |\n|-------------|----------------------------------------------------------|\n| Desde el segundo mes de vida | 120-150 (180) |\n| 1 – 2 años | 80-120 (150) |\n| 3- 5 años | 80-100 |\n| 6 -12 años | 60-80 |\n| 13-18 años | 50-70 |\n---\nLos requerimientos varían en función de la edad, peso, estado de hidratación y la enfermedad de base. Hay que tener en cuenta aquellas situaciones que aumentan las necesidades (fiebre, vómitos, diarrea) o las disminuyen (insuficiencia renal, insuficiencia cardiaca,\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}